A debate is in progress between alternative strategy prescriptions for degrowth. On the one side, what we might call ...
TORONTO--Cybin Inc. (Cboe CA: CYBN) (NYSE American: CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage ...